ACHN

Achillion Pharmaceuticals, Inc.
ACHN

Overview Fund Activity
Delisted

ACHN was delisted on the 27th of January, 2020.

Back to rankings

114 hedge funds and large institutions have $294M invested in Achillion Pharmaceuticals, Inc. in 2019 Q2 according to their latest regulatory filings, with 17 funds opening new positions, 34 increasing their positions, 30 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
114
Holders Change
+4
Holders Change %
+3.64%
% of All Funds
2.48%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
17
Increased
34
Reduced
30
Closed
10
Calls
$291K
Puts
$154K
Net Calls
+$137K
Net Calls Change
-$187K

Top Buyers

1
Nuveen Asset Management
Nuveen Asset Management
Illinois
+$7.81M
2
UBS Group
UBS Group
Switzerland
+$4.89M
3
BCPEMI
Bain Capital Public Equity Management II
Massachusetts
+$3.38M
4
Morgan Stanley
Morgan Stanley
New York
+$2.04M
5
Renaissance Technologies
Renaissance Technologies
New York
+$1.95M

Top Sellers

1
AC
Armistice Capital
New York
-$7.4M
2
Citadel Advisors
Citadel Advisors
Florida
-$2.61M
3
Millennium Management
Millennium Management
New York
-$2.19M
4
Axa
Axa
France
-$1.67M
5
Goldman Sachs
Goldman Sachs
New York
-$1.57M
Name Holding Trade Value Shares
Change 		Shares
Change %
RI
1
RTW Investments
New York
$37.2M +$308K +115,000 +0.8%
Vanguard Group
2
Vanguard Group
Pennsylvania
$32.9M +$869K +324,147 +3%
BlackRock
3
BlackRock
New York
$30.6M -$156K -58,336 -0.5%
Dimensional Fund Advisors
4
Dimensional Fund Advisors
Texas
$20.6M +$354K +132,270 +2%
MCO
5
MAK Capital One
New York
$18.6M – – –
Goldman Sachs
6
Goldman Sachs
New York
$17.5M -$1.57M -584,416 -8%
State Street
7
State Street
Massachusetts
$15.2M -$1.4M -521,259 -8%
UBS Group
8
UBS Group
Switzerland
$14.9M +$4.89M +1,824,534 +49%
Millennium Management
9
Millennium Management
New York
$11.6M -$2.19M -815,469 -16%
Renaissance Technologies
10
Renaissance Technologies
New York
$8.06M +$1.95M +728,000 +32%
RSCM
11
Rock Springs Capital Management
Maryland
$7.91M +$670K +250,000 +9%
Nuveen Asset Management
12
Nuveen Asset Management
Illinois
$7.81M +$7.81M +2,912,604 New
Citadel Advisors
13
Citadel Advisors
Florida
$5.69M -$2.61M -974,958 -31%
Geode Capital Management
14
Geode Capital Management
Massachusetts
$4.99M +$300K +112,082 +6%
SDIC
15
South Dakota Investment Council
South Dakota
$4.76M -$201K -74,875 -4%
Northern Trust
16
Northern Trust
Illinois
$4.31M -$43.9K -16,362 -1%
PAM
17
Panagora Asset Management
Massachusetts
$4M +$933K +348,164 +30%
BCPEMI
18
Bain Capital Public Equity Management II
Massachusetts
$3.38M +$3.38M +1,260,379 New
D.E. Shaw & Co
19
D.E. Shaw & Co
New York
$2.99M +$585K +218,241 +24%
BBA
20
Baker Bros. Advisors
New York
$2.94M – – –
OAM
21
Oxford Asset Management
United Kingdom
$2.58M +$30.7K +11,470 +1%
Morgan Stanley
22
Morgan Stanley
New York
$2.23M +$2.04M +760,761 +1,077%
Charles Schwab
23
Charles Schwab
California
$2.13M +$54.2K +20,215 +3%
CS
24
Candriam SCA
Luxembourg
$1.93M – – –
JPMorgan Chase & Co
25
JPMorgan Chase & Co
New York
$1.84M +$333K +125,310 +22%
1
2 3 4 5